ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1483-685830
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£713,000.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
ANGLE (LON:AGL) Frequently Asked Questions
What is ANGLE's stock symbol?
ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."
What price target have analysts set for AGL?
0 equities research analysts have issued 1 year target prices for ANGLE's shares. Their predictions range from GBX 110 to GBX 110. On average, they anticipate ANGLE's stock price to reach GBX 110 in the next year. This suggests a possible upside of 103.7% from the stock's current price. View Analyst Price Targets for ANGLE.
Has ANGLE been receiving favorable news coverage?
Media stories about AGL stock have been trending somewhat negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ANGLE earned a media sentiment score of -1.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of ANGLE's key competitors?
What other stocks do shareholders of ANGLE own?
Who are ANGLE's key executives?
ANGLE's management team includes the folowing people:
- Mr. Andrew David William Newland, Founder, CEO & Exec. Director (Age 57)
- Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 54)
- Dr. Daniel J. O'Shannessy, Chief Scientific Officer
- Mr. Paul Smith, VP & Chief Exec. Officer of ANGLE Biosciences Inc
- Mr. Martin Cooke, Director of Manufacturing & Regulatory Affairs (Age 50)
How do I buy shares of ANGLE?
Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is ANGLE's stock price today?
One share of AGL stock can currently be purchased for approximately GBX 54.
How big of a company is ANGLE?
ANGLE has a market capitalization of £77.42 million and generates £713,000.00 in revenue each year.
What is ANGLE's official website?
How can I contact ANGLE?
ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.
MarketBeat Community Rating for ANGLE (LON AGL)
MarketBeat's community ratings are surveys of what our community members think about ANGLE and other stocks. Vote "Outperform" if you believe AGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
